Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF Jan. 30, 2015 | Archived Issues

Recognition for Chugh, Danovitch, McGovern

Physician News

Sumeet S. Chugh, MD, has received a grant to study how to better predict sudden cardiac arrest, a group led by Itai Danovitch, MD, has published a guide to insurance options for coverage of addiction treatment, and Dermot P.B. McGovern, MD, PhD, has been elected a member of the International Organization for the Study of Inflammatory Bowel Disease.

» Read more


Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - January 2015


Milestones

Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue. Click here to email us your milestones and comments.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Recognition for Chugh, Danovitch, McGovern

Physician News

Chugh Awarded Grant to Help Predict Sudden Cardiac Arrest

Sumeet S. Chugh, MD, has received a $2.36 million grant to study how to better predict sudden cardiac arrest, a heart condition that kills an estimated 300,000 Americans each year.

Over recent years, Chugh and his team of researchers in the Cedars-Sinai Heart Institute have identified several risk factors for sudden cardiac arrest, including levels of sex hormones in the blood, genetics and electrical and structural abnormalities of the heart.

The new grant from the National Heart, Lung, and Blood Institute will support research with patients 35-59 years old. To date, most published studies have focused almost exclusively on patients 60 and older.

"Because fewer than 5 percent of sudden cardiac arrest patients survive, the only way we can protect patients is to be able to predict who is more likely to experience the condition," said Chugh, associate director of the Cedars-Sinai Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research.

Danovitch Leads California Society of Addiction Medicine and Its Consumer Education Initiative

The California Society of Addiction Medicine, whose president is Cedars-Sinai chair of Psychiatry Itai Danovitch, MD, has published a guide to help consumers better understand differences among health insurance options for coverage of addiction treatment.

Though all plans cover substance use disorders and there is some degree of standardization, there are several areas, such as methadone treatment and pharmacy benefits, where there are significant differences among plans.

The group published its "Consumer Guide and Scorecard for Health Insurance Coverage in California for Substance Use Disorders and Mental Health" to coincide with the open enrollment period of the Covered California health insurance exchange.

"The goal of the California Society of Addiction Medicine's project is to help empower consumers by demystifying the elements of addiction treatment and providing information about what is covered by different insurance plans," Danovitch said.

McGovern Elected to International IBD Organization

Dermot P.B. McGovern, MD, PhD, has been elected a member of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD). The organization is limited to 50 members worldwide.

McGovern is director of Translational Medicine at the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute.

The mission of the IOIBD is to promote the health of people with IBD worldwide by setting the direction for patient care, education and research. Task forces of IOIBD promote scientific developments by designing noncommercial clinical studies. Grants are provided for innovative startup projects and large-scale trials.